Login
Franklin Genomic Advancements ETF CBOE - exBATS: HELX
Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life
| Name | Franklin Genomic Advancements ETF |
| Ticker | HELX |
| Exchange | CBOE - exBATS |
| Category | Health Care |
| Sub Category | Biotech |
| Price | 50.04 |
| 52W Low/High | 19.17 / 50.60 |
| AUM | - |
| 1Y Total Return |
108.84%
Strong |
| 1Y Volatility |
35.87%
Average Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Franklin Genomic Advancements ETF seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life
Details
| Ticker | HELX |
| Name | Franklin Genomic Advancements ETF |
| ISIN | |
| CUSIP | |
| Exchange | CBOE - exBATS |
| Category | Health Care |
| Sub Category | Biotech |
| Country | USA |
| Currency | U.S. Dollar |
| Benchmark | - |
Share as of 1/15/21
| Close Price | 50.04 |
| 52W Low/High | 19.17 / 50.60 |
| 1Y Total Return |
108.84%
Strong |
| 1Y Volatility |
35.87%
Average Risk |
| Beta | 0.01 |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dist. Frequency | - |
| Dividend Yield | - |
Data as of 1/19/21
| AUM | - |
| Discount/Premium | - |
| NAV | - |
| Shares Outstanding | - |
| Volume 20D Avg | - |
| Nbr of Holdings | - |
| ETF Global Risk Rank | - |
| Net Expense | - |
| Options Available | - |
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available